- Home
- NCNA vs LIPO Comparison
NCNA vs LIPO Comparison
Compare NCNA & LIPO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NCNA
- LIPO
- Stock Information
- Founded
- NCNA 1997
- LIPO 2005
- Country
- NCNA United Kingdom
- LIPO United States
- Employees
- NCNA N/A
- LIPO N/A
- Industry
- NCNA Biotechnology: Pharmaceutical Preparations
- LIPO Biotechnology: Pharmaceutical Preparations
- Sector
- NCNA Health Care
- LIPO Health Care
- Exchange
- NCNA Nasdaq
- LIPO Nasdaq
- Market Cap
- NCNA 4.3M
- LIPO 3.8M
- IPO Year
- NCNA 2017
- LIPO 2022
- Fundamental
- Price
- NCNA $1.14
- LIPO $2.85
- Analyst Decision
- NCNA Buy
- LIPO Strong Buy
- Analyst Count
- NCNA 2
- LIPO 1
- Target Price
- NCNA $25.00
- LIPO $16.00
- AVG Volume (30 Days)
- NCNA 238.3K
- LIPO 91.5K
- Earning Date
- NCNA 11-25-2024
- LIPO 02-25-2025
- Dividend Yield
- NCNA N/A
- LIPO N/A
- EPS Growth
- NCNA N/A
- LIPO N/A
- EPS
- NCNA N/A
- LIPO N/A
- Revenue
- NCNA N/A
- LIPO $483,533.00
- Revenue This Year
- NCNA N/A
- LIPO N/A
- Revenue Next Year
- NCNA N/A
- LIPO N/A
- P/E Ratio
- NCNA N/A
- LIPO N/A
- Revenue Growth
- NCNA N/A
- LIPO 0.78
- 52 Week Low
- NCNA $0.96
- LIPO $2.21
- 52 Week High
- NCNA $19.40
- LIPO $12.00
- Technical
- Relative Strength Index (RSI)
- NCNA 43.15
- LIPO 45.72
- Support Level
- NCNA $0.96
- LIPO $2.78
- Resistance Level
- NCNA $1.37
- LIPO $3.17
- Average True Range (ATR)
- NCNA 0.15
- LIPO 0.29
- MACD
- NCNA -0.00
- LIPO -0.04
- Stochastic Oscillator
- NCNA 26.09
- LIPO 7.61
About NCNA NuCana plc
NuCana PLC is a biopharmaceutical company focused on improving treatment outcomes for cancer patients by ProTide technology. Utilizing proprietary ProTide technology, the firm is developing new medicines designed to overcome key cancer resistance mechanisms and generate much higher concentrations of anti-cancer metabolites in cancer cells. The company's ProTide pipeline products are NUC-3373, NUC-7738, Acelarin. Geographically operates through the region of the United States.
About LIPO Lipella Pharmaceuticals Inc.
Lipella Pharmaceuticals Inc is a clinical-stage biotechnology company. The company is focused on developing new drugs by reformulating the active agents in existing generic drugs and optimizing these reformulations for new applications. The company's product candidates include LP-10, LP-310 and LP-410 which can be helpful in treatment of Hemorrahagic Cystitis, Oral Licen Planus and Oral Graft.